Despite reports showing that IRF4 plays an oncogenic role in promoting lymphomagenesis via downregulation of BCL2 family proteins, such as BIM and BMF,41 we revealed that IRF4 directly interacts with BCL2 in DLBCL. The gene discussed is BCL2L11; the disease is diffuse large B-cell lymphoma.